Related Experiment Video

Updated: May 17, 2026

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

Metabolic syndrome is a risk factor for development of heart failure in acute myocardial infarction

M A Bari1, M S Islam, G K Paul

  • 1Department of Cardiology, Mymensingh Medical College, Bangladesh.

Mymensingh Medical Journal : MMJ
|November 9, 2012
PubMed

Insights

Metabolic syndrome significantly increases the risk of developing heart failure in patients with acute myocardial infarction (AMI). This finding highlights the critical link between metabolic health and cardiac outcomes.

Area of Science:

  • Cardiology
  • Metabolic Disorders

Background:

  • Metabolic syndrome is a cluster of conditions that increase the risk of heart disease, stroke, and diabetes.
  • Heart failure is a major cause of morbidity and mortality worldwide.
  • The association between metabolic syndrome and heart failure requires further investigation, particularly in the context of acute myocardial infarction (AMI).

Purpose of the Study:

  • To investigate the association between metabolic syndrome and the development of heart failure in patients with AMI.
  • To compare the incidence of heart failure in AMI patients with and without metabolic syndrome.

Main Methods:

  • A case-control study was conducted with 100 patients diagnosed with AMI.
  • Patients were divided into two groups: Group A (50 patients with AMI and metabolic syndrome) and Group B (50 patients with AMI without metabolic syndrome).
  • Data were collected from August 2009 to May 2010 at the Department of Cardiology, Mymensingh Medical College, Mymensingh.

Main Results:

  • Heart failure developed in 23 (46%) patients in Group A (AMI with metabolic syndrome).
  • Heart failure developed in 10 (20%) patients in Group B (AMI without metabolic syndrome).
  • The difference in heart failure development between the two groups was statistically significant (p<0.05).

Conclusions:

  • Metabolic syndrome is significantly associated with an increased risk of heart failure in patients experiencing acute myocardial infarction.
  • These findings underscore the importance of managing metabolic syndrome to mitigate cardiac complications after AMI.

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...